Study to evaluate the effect of Dienogest on Estradiol Valerate pharmacokinetics in postmenopausal women
Please see attached Study Results Summary below.
No Inclusion Criteria Available
No Exclusion Criteria Available
Open-label, randomized, two-way crossover study to assess the effect of dienogest on estradiol valerate pharmacokinetics after single oral administration of two different microcrystalline suspensions containing 4 mg estradiol valerate or 4 mg estradiol valerate + 4 mg dienogest in 24 healthy postmenopausal volunteers